Puerto Rico set to achieve life science export potential
Air trade demand from Puerto Rico (PR) to mainland US reflects its growing life science ...
Well-documented fears from incumbents that Amazon has set its sights on the pharmaceutical market have been waylaid – for now at least. The news follows its admission to regulators that it will not use its pharmacy licences to sell prescriptions, but to sell medical devices and supplies instead. The etailer had gained licences from Tennessee and Indiana – but analyst Jeffries, through a freedom of information request, discovered that its application stated it would “not store or ship drugs”. Neverthless, it may perhaps have opted for “lower-hanging fruit” first, before it moves into the drug market. However, an analyst at Pembroke Consulting believes that the pharma market could be a tough one to crack, even for Amazon.
'Mass-casualty incident' as Maersk box ship destroys Baltimore bridge
Shock for CMA CGM as a deputy CEO decides to quit
Diversions from Red Sea proving a real ‘silver lining’ for carriers
Could the Dali have suffered a power loss before bridge crash?
Asia-Europe carriers revise FAK rates in fight to rein in revenue erosion
Strike paralysing Finnish ports extended after talks collapse
Indian Customs to auction uncleared export boxes at Nhava Sheva
Alex Lennane
email: [email protected]
mobile: +44 7879 334 389
During August 2023, please contact
Alex Whiteman
email: [email protected]
Alessandro Pasetti
email: [email protected]
mobile: +44 7402 255 512
Comment on this article